Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: Report of two cases
Open Access
- 1 January 2015
- journal article
- case report
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (4) , 1329-33
Abstract
Mixed adenoneuroendocrine carcinoma (MANEC) is a rare tumor of the gastrointestinal tract that consists of a dual adenocarcinomatous and neuroendocrine differentiation, each component representing at least 30% of the tumor. To date, only seven cases have been reported in the cecum, and less than 40 in the stomach. Our first case was diagnosed in a 74-years-old female as a polypoid lesion of the cecum with direct invasion in the transverse colon, without lymph node metastases. The second case was diagnosed in the stomach of a 46-years-old male as a polypoid tumor of the antral region that invaded the pancreas and presented metastases in 22 regional lymph nodes. The metastatic tissue was represented by the glandular component. In both cases, the tumor consisted of a moderately-differentiated tubular adenocarcinoma (with mucinous component in Case 1) intermingled with neuroendocrine carcinoma. Ki67 index was lower than 20% in Case 1, respectively higher than 20% in Case 2. The neuroendocrine component was marked by synaptophysin and neuron specific enolase, being negative for Keratins 7/20. The neuroendocrine component represented 60% in Case 1, and 40% in Case 2, respectively. The glandular components were marked by carcinoembryonic antigen, maspin and keratin 20/7 (Case 1/2). Both cases were proved to be microsatellite stable. Independently by the localization and tumor stage, MANECs appear to be highly malignant tumors, with high risk for distant metastases. The aggressiveness seems to depend on the endocrine component, independent of its proportion. The neuroendocrine component could be a dedifferentiated adenocarcinoma with a neuroendocrine phenotype.Keywords
This publication has 12 references indexed in Scilit:
- Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinomaOncology Letters, 2013
- Clinicopathologic Significance of Putative Stem Cell Marker, CD44 and CD133, in Human Gastric CarcinomaJournal of Surgical Oncology, 2013
- Mixed Adenoneuroendocrine Carcinoma of Cecum: A Rare EntityJournal of Clinical Imaging Science, 2013
- Practical value of the new system for Maspin assessment, in colorectal cancer.Neoplasma, 2013
- Expression of CD133 in Neuroendocrine Neoplasms of the Digestive Tract: A Detailed Immunohistochemical AnalysisThe Tohoku Journal of Experimental Medicine, 2013
- Mixed adeno(neuro)endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagusWorld Journal of Surgical Oncology, 2013
- A Gastric Composite Tumor with an Adenocarcinoma and a Neuroendocrine Carcinoma: A Case ReportClinical Endoscopy, 2013
- Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995–2012) in South ChinaBMC Endocrine Disorders, 2012
- Clinicopathologic Significance of Gastric Adenocarcinoma with Neuroendocrine FeaturesJournal of Gastric Cancer, 2011
- [Treatment of sequelace of corneal wounds].1977